Blogs
Advertisement
The somewhat-awkwardly named TransCelerate BioPharma immediately got an enthusiastic reception from industry watchers and participants, mainly due to the perception that it was well poised to attack some of the systemic causes of delays and cost overruns that plague clinical trials today.
Advertisement
Advertisement
An entire section of Horizon 2020 is devoted to health, demographic change, and well-being.
Clinical trials community reacts favorably to tentative set of new rules, yet questions remain.
Proposed rule changes on public information in Europe never make it to fruition.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
CNS and Autoimmune Trials: Growth and Operational Implications
3
ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
